Add Company
Join Now

Polyneuron Pharmaceuticals AG Revenue and Competitors

License our Company Data API

Basel,

Location

N/A

Total Funding

Pharma

Industry

Estimated Revenue & Valuation

  • Polyneuron Pharmaceuticals AG's estimated annual revenue is currently $1M per year.(i)
  • Polyneuron Pharmaceuticals AG's estimated revenue per employee is $201,000

Employee Data

  • Polyneuron Pharmaceuticals AG has 5 Employees.(i)
  • Polyneuron Pharmaceuticals AG grew their employee count by -74% last year.

Polyneuron Pharmaceuticals AG's People

NameTitleEmail/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$46.2M2305%N/AN/A
#2
$43.8M21821%N/AN/A
#3
$57.1M28426%N/AN/A
#4
$24.5M1223%N/AN/A
#5
$52.9M26313%N/AN/A
#6
$24.7M12313%N/AN/A
#7
$1.8M180%$114.3MN/A
#8
$7.2M36-20%N/AN/A
#9
$13.7M68-7%N/AN/A
#10
$7.6M39-13%$123.9MN/A
Add Company

What Is Polyneuron Pharmaceuticals AG?

Polyneuron is a growing Basel-based biotechnology company active in the area of autoimmune disease treatments. The company was founded in 2014 as a spinout company from the University of Basel to develop novel treatments to combat immune disorders using its Antibody-Catchâ„¢ technology platform. The company currently employs about 10 people and has raised a significant amount in equity funding from top-tier VCs. We are a team of passionate and experienced scientists, entrepreneurs and investors willing to bring new therapies to patients.

keywords:N/A

N/A

Total Funding

5

Number of Employees

$1M

Revenue (est)

-74%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Polyneuron Pharmaceuticals AG News

2022-02-22 - Polyneuron and University of Basel Awarded Grant of CHF 1.2M to ...

BASEL, Switzerland--(BUSINESS WIRE)--Polyneuron Pharmaceuticals AG, a clinical-stage developer of a new class of antigen-specific polymers...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$0.4M50%N/A
#2
$1.2M6-50%N/A
#3
$0.4M7-12%N/A
#4
$0.6M814%N/A
#5
$0.6M8N/AN/A